Brief: Kane Biotech private placement offering of up to 50 mln shares
02/06/2016 22:33
June 2 (Reuters) - Kane Biotech Inc KNE.V
* Kane biotech announces private placement offering and
proposed consolidation of shares
* Net proceeds of offering will be used for development and
marketing of company's products
* Has agreed to seek approval of its shareholders for a
consolidation of common shares on a five to one basis
* Non-Brokered private placement offering of up to 50
million common shares at a price of $0.03 per common share
Source text for Eikon: ID:nCCN1GsdzW
Further company coverage: KNE.V
(Bengaluru Newsroom: +1-646-223-8780)
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update